Sinus histocytosis with massive lymphadenopathy (Rosai-Dorfman disease) in a patient with primary Sjogren's syndrome

Scandinavian Journal of Rheumatology

Volumn 33, Issue 2, 2004, Pages 119-122

  Drosos, A A ^a,b   Georgiadis, A N ^a   Metafratzi, Z M ^b   Voulgari, P V ^a   Efremidis, S C ^b   Bai, M ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CERVICAL LYMPH NODE; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; HUMAN; HUMAN TISSUE; INFECTION; LYMPHADENOPATHY; LYMPHOPROLIFERATIVE DISEASE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; ROSAI DORFMAN DISEASE; SINUS HISTIOCYTOSIS; SINUS HISTIOCYTOSIS WITH MASSIVE LYMPHADENOPATHY; SJOEGREN SYNDROME; SPLENOMEGALY; THORAX RADIOGRAPHY;

BIOPSY, NEEDLE; FOLLOW-UP STUDIES; HISTIOCYTOSIS, SINUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 1842607153     PISSN: 03009742     EISSN: None     Source Type: Journal    
DOI: 10.1080/03009740310004739     Document Type: Article

References (11)

1. Moutsopoulos HM. Sjogren's syndrome. In: E Braunwald, AS Fauci, DL Kasper, SL Hauser, DL Longo, JL Jameson. Harrison's principles of internal medicine. 15th ed. New York: McGraw-Hill; 2001. p. 1947-8.
2. Drosos AA, Tsiakou EK, Tsifetaki N, Politi EN, Siamopoulou-Mavridou A. Subgroups of primary Sjogren's syndrome: Sjogren's syndrome in male and paediatric Greek patients. Ann Rheum Dis 1997;56:333-5.
3. Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
4. Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum 2000;29:296-304.
5. Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM, and the Members of the European Concerted Action on Sjogren's syndrome. Malignant lymphoma in primary Sjogren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren's Syndrome. Arthritis Rheum 1999;42:1765-72.
6. Rosai J, Dorfman RF. Sinus histiocytosis massive lymphadenopathy: a pseudolymphomatous benign disorder: analysis of 34 cases. Cancer 1972;30:1174-88.
7. Pulsoni A, Anghel G, Falcucci P, Matera R, Pescarmona E, Ribersani M, et al. Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review. Am J Hematol 2002;69:67-71.
8. Chisholm DM, Mason DK. Labial salivary gland biopsy in Sjogren's disease. J Clin Pathol 1968;21:656-60.
9. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjogren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-7.
10. Miettinen M, Paljiakka P, Haveri P, Saxen E. Sinus histiocytosis with massive lymphadenopathy: a nodal and extranodal proliferation of S-100 protein positive histiocytes? Am J Clin Pathol 1997;88:270-7.
11. Foucar E, Rosai J, Dorfman RF, Eyman JM. Immunologic abnormalities and their significance in sinus histiocytosis with massive lymphadenopathy. Am J Clin Pathol 1984;82: 515-25.